This site is intended for healthcare professionals
Login
Register
Medical education
Specialty
News
Congresses
Search
Search
Menu
Home
Medical education
Specialty
News
Congresses
Search
Home
/
Medical education
/
Psoriasis Academy – Overview
/
EADV 2021 videos
/
Why was tildrakizumab evaluated for treating psori...
Why was tildrakizumab evaluated for treating psoriasis in the POSITIVE study?
Psoriasis Academy – Overview
The Academy
Patient-centred care in psoriasis
Psoriasis Management
Psoriasis Treatment
Key evidence on psoriasis treatments
Psoriasis Guidelines
Expert opinion – patient wellbeing in psoriasis
Feedback
Bookmark
Bookmarked
Top
